Matthew Shelley

Matthew Shelley is an associate in Goodwin’s Technology and Life Sciences groups in London. Mr. Shelley advises clients on a broad range of corporate matters, with a focus on transactions in the life sciences, healthcare, and technology sectors. He has particular experience advising on private equity and venture capital investments/exits, mergers and acquisitions, corporate finance, and re-organizations as well as general corporate matters.

• Forbion (via its new BioEconomy Fund) and FMC Ventures on their investment in the oversubscribed $14 million Series A funding round for SOLASTA Bio. Established in 2021, Glasgow-based SOLASTA Bio has developed the world's first technology platform for creating insect control agents that are nature-inspired rather than selected from a synthetic chemistry library.
• Novo Holdings on its lead investment into Roslin Tech, as part of a financing round of £11 million. Roslin Tech is an agriculture biotechnology company, which is developing and commercializing novel biotechnologies for alternative protein sectors and animal health.
• Grip, an event networking app, on its $13 million Series A financing round led by Kennet Partners.
• KaNDy Therapeutics, a private clinical-stage biotech, on its sale to Bayer for $425 million upfront with up to $450 million in development milestone payments and triple digit millions in commercial milestones.
• Nodthera, a biotechnology company developing a new class of potent and selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation, on its $55 million Series B equity financing.
• Omers Ventures, the London based venture capital arm of Canadian pension fund Omers, on its Series A investment into Quorso, a business analytics and performance platform.
• Omers Ventures, as lead investor on its investment into FirstVet as part of a €18.5 million Series B financing round. FirstVet is a Swedish startup that provides pet owners with on-demand video consultations with local, qualified veterinarians.
• CRV, as lead investor on its investment into GTMHUB, which provides software and services for organisational planning, as part of a $9 million Series A financing round.
• Duffel, a travel distribution platform, on its $30 million Series B financing round which was led by Index Ventures and with participation from previous venture capital investors.
• AGC Equity Partners on the sale of 25 Canada Square, currently the largest office building in the United Kingdom.*
• Welsh, Carson, Anderson & Stowe, a leading US private equity firm focused primarily on technology and healthcare sectors, on the sale of its portfolio business AIM Software, a leading provider of data management solutions with a specialized focus on the buy-side, to SimCorp, a Danish listed entity, for an enterprise value of €60 million.*
• HRA Pharma, a portfolio company of Astorg Partners, on the acquisition of the Mederma Brand from Merz Pharmaceuticals GmbH.*

* Denotes experience prior to joining Goodwin